Cargando…
Gene editing for corneal disease management
Gene editing has recently emerged as a promising technology to engineer genetic modifications precisely in the genome to achieve long-term relief from corneal disorders. Recent advances in the molecular biology leading to the development of Clustered Regularly Interspaced Short Palindromic Repeats (...
Autores principales: | Raikwar, Sudhanshu P, Raikwar, Apoorva S, Chaurasia, Shyam S, Mohan, Rajiv R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221704/ https://www.ncbi.nlm.nih.gov/pubmed/35757280 http://dx.doi.org/10.5528/wjtm.v5.i1.1 |
Ejemplares similares
-
PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice
por: Raikwar, Sudhanshu P, et al.
Publicado: (2012) -
Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?
por: Raikwar, Sudhanshu P., et al.
Publicado: (2018) -
Nanomedicine Approaches for Corneal Diseases
por: Chaurasia, Shyam S., et al.
Publicado: (2015) -
Human iPS Cell-Derived Insulin Producing Cells Form Vascularized Organoids under the Kidney Capsules of Diabetic Mice
por: Raikwar, Sudhanshu P., et al.
Publicado: (2015) -
Aldosterone regulates a 5ʹ variant sgk1 transcript via a shared hormone response element in the sgk1 5ʹ regulatory region
por: Raikwar, Nandita S., et al.
Publicado: (2017)